@incollection{,
	
					
					
					292B0D3B40575E74BC5079F29FD91FA0
				,
	author={{Mehul B.Vyas} and {DhavalPatel} and {Dr. SamirK.Shah} and {SARDAR PATEL COLLEGE OF PHARMACY, GUJARAT TECHNOLOGICAL UNIVERSITY}},
	journal={{Global Journal of Medical Research}},
	journal={{GJMR}}2249-46180975-588810.34257/GJMR,
	address={Cambridge, United States},
	publisher={Global Journals Organisation}1521934
}

@incollection{b0,
	
	
		,
	title={{Current therapy of allergic conjunctivitis}}
		,
	author={{
			MBisca
		}}
	
	
		,
	journal={{Current Therapeutic Research}}
		
			58
			
			,
	year={1997}
		
	

}

@incollection{b1,
	
	
		,
	title={{Industrial perspective in ocular drug delivery}}
		,
	author={{
			AliYa
		} and {
			KLehmussaari
		}}
		
	
	
		,
	journal={{Advanced Drug Delivery Reviews}}
		
			58
			
			,
	year={2006}
		
	

}

@incollection{b2,
	
	
		,
	title={{An overview and advancement in ocular drug delivery systems}}
		,
	author={{
			Rathore
		}}
	
	
		,
	journal={{International Journal of Pharmaceutical Science & Research}}
		
			46
			
			,
	year={2010}
		
	

}

@incollection{b3,
	
	
		,
	title={{Current and future ophthalmic drug delivery systems, A Shift to the posterior segment}}
		,
	author={{
			MEva
		} and {
			AtourttiDel Amo
		}}
		
	
	
		,
	journal={{Drug Discovery Today}}
		
			13
			
			,
	year={2008}
		
	

}

@incollection{b4,
	
	
		,
	title={{Ocular pharmacokinetics}}
		,
	author={{
			MauriceDm
		} and {
			SPMishima
		}}
		
	
	
		,
	journal={{Handbook Of Experimental Pharmacology}}
		
			
			,
	year={1984}
			,
	publisher={Berlin-Heidelberg Publication}
		
	
	,
	note={15th Edition}

}

@incollection{b5,
	
	
		,
	title={{Recent perspectives in ocular drug delivery-expert review}}
		,
	author={{
			RipalGaudana
		} and {
			AndSaih
		} and {
			A
		}}
		
		
	
	
		,
	journal={{Pharmaceutical Research}}
		
			26
			
			,
	year={2009}
		
	

}

@incollection{b6,
	
	
		,
	title={{Dexamethasone eye drops containing alpha cyclodextrin-based nanogels}}
		,
	author={{
			MariaDMoya-Ortega
		}}
	
	
		,
	journal={{International Journal of Pharmaceutics}}
		
			44
			
			,
	year={2013}
		
	

}

@incollection{b7,
	
	
		,
	title={{Microemulsion as potential drug delivery system}}
		,
	author={{
			AnsariMj
		} and {
			Kohli
		}}
		
	
	
		,
	journal={{Pdaj. Pharma Science Techno}}
		
			62
			
			,
	year={2008}
		
	

}

@incollection{b8,
	
	
		,
	title={{Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs}}
		,
	author={{
			MAKassem
		} and {
			AAAbdelrahman
		}}
		
	
	
		,
	journal={{Int. J. Pharm}}
		
			340
			
			,
	year={2007}
		
	

}

@incollection{b9,
	
	
		,
	title={{Liposomes as an ocular delivery system for acetazolamide: in-vitro and in vivo studies}}
		,
	author={{
			RMHathout
		} and {
			SMansour
		}}
		
	
	
		,
	journal={{Aaps Pharm scitech}}
		
			8
			1
			,
	year={2007}
		
	

}

@incollection{b10,
	
	
		,
	title={{Poly (amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide}}
		,
	author={{
			TFVandammeand
		} and {
			LBrobeck
		}}
		
	
	
		,
	journal={{J. Control Release}}
		
			4
			
			,
	year={2007}
		
	

}

@incollection{b11,
	
	
		,
	title={{Vesicular systems in ocular drug delivery}}
		,
	author={{
			KaurIp
		}}
	
	
		,
	journal={{Int. J. Pharm}}
		
			2
			
			,
	year={2010}
		
	

}

@book{b12,
	
	
		,
	title={{Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles}}
		,
	author={{
			JLBourges
		} and {
			SEGautier
		}}
		
		
	
	,
	note={Invest}

}

@incollection{b13,
	
	
		,
	title={{}}
	
	
		,
	journal={{Ophthalmol. Vis. Sci}}
		
			44
			
			,
	year={2003}
		
	

}

@incollection{b14,
	
	
		,
	title={{Intraocular implants for extended drug delivery: therapeutic applications}}
		,
	author={{
			JLBourges
		} and {
			FBehar-Cohen
		}}
		
	
	
		,
	journal={{Adv. Drug Delivery Review}}
		
			58
			
			,
	year={2006}
		
	

}

@incollection{b15,
	
	
		,
	title={{Topical and systemic absorption in delivery of dexamethasone to the anterior and posterior segments of the eye}}
		,
	author={{
			SigurdssonHh
		} and {
			EStefansson
		}}
		
	
	
		,
	journal={{Acta. Ophthalmol. Scand}}
		
			85
			
			,
	year={2007}
		
	

}

@incollection{b16,
	
	
		,
	title={{Ophthalmic drug delivery through contact lenses}}
		,
	author={{
			DGulsenand
		} and {
			AChauhan
		}}
		
	
	
		,
	journal={{Invest Ophthalmol Vis Science}}
		
			45
			
			,
	year={2004}
		
	

}

@incollection{b17,
	
	
		,
	title={{A novel approach sustained ocular drug delivery: In-situ Gel}}
		,
	author={{
			HiteshSharma
		}}
	
	
		,
	journal={{International Journal of Research in Pharmacy and Life Science}}
		
			1
			2
			
			,
	year={2013}
		
	

}

@incollection{b18,
	
	
		,
	title={{Current ocular drug delivery challenges for N-acetyloxcarnosine: novel patented routes and modes of delivery, design for enhancement of therapeutic activity and drug delivery relationships}}
		,
	author={{
			AMark
		} and {
			Babizhayev
		}}
		
	
	
		,
	journal={{Drug Delivery & Formulation}}
		
			18
			
			,
	year={2009}
		
	
	,
	note={Recent Patents on}

}

@incollection{b19,
	
	
		,
	title={{Tolerance of ocular iontophoresis in healthy volunteers}}
		,
	author={{
			TMParkinson
		} and {
			MMundasad
		}}
		
	
	
		,
	journal={{J. Ocul. Pharmacol. Therapy}}
		
			19
			
			,
	year={2003}
		
	

}

@incollection{b20,
	
	
		,
	title={{Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy}}
		,
	author={{
			KJoossand
		} and {
			NChirmule
		}}
		
	
	
		,
	journal={{Gene Therapy}}
		
			10
			
			,
	year={2003}
		
	

}

@incollection{b21,
	
	
		,
	title={{An insight into ophthalmic drug delivery system}}
		,
	author={{
			KSRathore
		} and {
			RKNima
		}}
		
	
	
		,
	journal={{International Journal of Pharmaceutical Science and Drug Research}}
		
			47
			
			,
	year={2009}
		
	

}

@book{b22,
	
	
		,
	title={{The Handbook of Ocular Disease Management}}
		
	

}

@book{b23,
	
	
		,
	title={{Allergic conjunctivitis: update on pathophysiology and prospects for future treatment}}
		,
	author={{
			SantaJMark
		} and {
			BA
		}}
		
		
	

}

@book{b24,
	
	
		,
	title={{United State Pharmacopeia and National Formulary (USP 30)}}
		
			2707
		
	
	,
	note={Naphazoline Hydrochloride Monograph}

}

@book{b25,
	
	
		,
	title={{United State Pharmacopeia and National Formulary (USP 30)}}
		
	
	,
	note={Pheniramine Maleate Monograph}

}

@incollection{b26,
	
	
		,
	title={{The use of mucoadhesive polymers in ocular drug delivery}}
		,
	author={{
			Annickludwig
		}}
	
	
		,
	journal={{Advanced Drug Delivery Reviews}}
		
			7
			
			,
	year={2005}
		
	

}

@incollection{b27,
	
	
		,
	title={{Influence of the physico-chemical properties of ophthalmic viscolysers on the weight of drops dispensed from a flexible dropper bottle}}
		,
	author={{
			VanSantvliet
		} and {
			AKLudwig
		}}
		
	
	
		,
	journal={{European Journal of Pharmaceutical Sciences}}
		
			95
			
			,
	year={1999}
		
	

}

@incollection{b28,
	
	
		,
	title={{Mucoadhesive nanopolymer -a novel drug carrier for topical ocular drug delivery}}
		,
	author={{
			Soumendra Sahoo
		} and {
			Al
		}}
		
	
	
		,
	journal={{European Journal of Scientific Research}}
		
			46
			
			,
	year={2010}
		
	

}

@book{b29,
	
	
		,
	title={{Handbook of Pharmaceutical Excipients}}
		,
	author={{
			CRaymond
		} and {
			Rowa
		} and {
			CSiân
		} and {
			Owen
		}}
		
		
		
		
			,
	year={2006}
			,
	publisher={The Pharmaceutical Press}
			
		
	
	,
	note={6 th edn}

}

@incollection{b30,
	
	
		,
	title={{Tamarind seed polysaccharide: a versatile biopolymer for mucoadhesive applications}}
		,
	author={{
			SahooSoumendra
		}}
	
	
		,
	journal={{Journal of Pharmaceutical and Biomedical Sciences}}
		
			8
			20
			,
	year={2010}
		
	

}

@book{b31,
	
	
		,
	title={{Handbook of Pharmaceutical Excipients}}
		,
	author={{
			CRaymond
		} and {
			Rowa
		} and {
			CSiân
		} and {
			Owen
		}}
		
		
		
		
			,
	year={2006}
			,
	publisher={The Pharmaceutical Press}
			
		
	
	,
	note={6 th edn}

}

@book{b32,
	
	
		,
	title={{Handbook of Pharmaceutical Excipients}}
		,
	author={{
			CRaymond
		} and {
			Rowa
		} and {
			CSiân
		} and {
			Owen
		}}
		
		
		
		
			,
	year={2006}
			,
	publisher={The Pharmaceutical Press}
			
		
	
	,
	note={6 th edn}

}

@incollection{b33,
	
	
		,
	title={{A comparative rheological study on carbopol viscous solutions and evaluation of their suitability as the ophthalmic vehicle and artificial tears}}
		,
	author={{
			NUnlu
		} and {
			ALudwig
		}}
		
	
	
		,
	journal={{Pharma Act}}
		
			67
			1
			
			,
	year={1992}
		
	

}

@incollection{b34,
	
	
		,
	title={{A poloxamer/chitosan in situ forming gel with prolonged retention time for ocular delivery}}
		,
	author={{
			ViannaLopez
		}}
	
	
		,
	journal={{European Journal of Pharmaceutics and Biopharmaceutics}}
		
			75
			
			,
	year={2010}
		
	

}

@incollection{b35,
	
	
		,
	title={{Synergistic interaction between TS-polysaccharide and hyaluronic acid: implications in the formulations of eye drops}}
		,
	author={{
			GUBarretta
		} and {
			SNazzi
		}}
		
	
	
		,
	journal={{International Journal of Pharmaceutics}}
		
			395
			
			,
	year={2011}
		
	

}

@incollection{b36,
	
	
		,
	title={{Formulation and Invitro evaluation of cysteamine hydrochloride viscous solution for treatment of corneal cystinosis}}
		,
	author={{
			KoraygumSibelbozdag
		}}
	
	
		,
	journal={{European Journal of Pharmaceutics and Biopharmaceutics}}
		
			70
			
			,
	year={2008}
		
	

}

@incollection{b37,
	
	
		,
	title={{Pheniramine maleate/naphazoline hydrochloride ophthalmic solution and olopatadine hydrochloride ophthalmic solution in the conjunctival allergen challenge model}}
		,
	author={{
			VGJack
		}}
	
	
		,
	journal={{Clinical Therapeutics}}
		
			27
			,
	year={2005}
		
	

}

@incollection{b38,
	
	
		,
	title={{In-situ gelling xyloglucan formulations for sustained release ocular delivery of pilocarpine hydrochloride}}
		,
	author={{
			DAttwood
		}}
	
	
		,
	journal={{International Journal of Pharmaceutics}}
		
			229
			,
	year={2001}
		
	

}

@incollection{b39,
	
	
		,
	title={{Formulation and evaluation of ophthalmic preparations of acetazolamide}}
		,
	author={{
			IPKaur
		}}
	
	
		,
	journal={{International Journal of Pharmaceutics}}
		
			199
			
			,
	year={2000}
		
	

}

@incollection{b40,
	
	
		,
	title={{Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention}}
		,
	author={{
			OFelt
		}}
	
	
		,
	journal={{International Journal of Pharmaceutics}}
		
			180
			
			,
	year={1999}
		
	

}

@book{b41,
	
	
		,
	title={{Eye preparation for treating medicine, US Patents 03132242}}
		,
	author={{
			FormingJingcai
		}}
		
			,
	year={2004}
		
	

}

@book{b42,
	
	
		,
	title={{Method and composition for treatment of skin conditions, US Patents PCT}}
		,
	author={{
			JeffreyHutterer
		}}
		
			,
	year={US2005/010269,2005}
		
	

}

@book{b43,
	
	
		,
	title={{Ophthalmic compositions including glycerin and propylene glycol, US Patents US 08/794}}
		,
	author={{
			JohnDenick
		} and {
			ZhenzeHu
		}}
		
		
			,
	year={1998}
			690
		
	

}

@book{b44,
	
	
		,
	title={{Ketorolac tromethamine compositions for treating ocular pain}}
		,
	author={{
			Farnes
		}}
		US Patents 12/396
		
			,
	year={2009}
			131
		
	

}

@book{b45,
	
	
		,
	title={{Ophthalmic formulation, US Patents US 081329}}
		,
	author={{
			OrestOlejnik
		} and {
			FredWWendel
		}}
		
		
			,
	year={1997}
			808
		
	

}

@incollection{b46,
	
	
		,
	title={{Improved ocular: systemic absorption ratio of timolol by viscous vehicle and phenylephrine}}
		,
	author={{
			KrisriinoKyyronen
		} and {
			Arrourrri
		}}
		
	
	
		,
	journal={{Investigative Ophthalmology & Visual Science}}
		
			15
			
			,
	year={1990}
		
	

}

@incollection{b47,
	
	
		,
	title={{Formulation and Invitro evaluation of cysteamine hydrochloride viscous solution for treatment of corneal cystinosis}}
		,
	author={{
			KoraygumSibelbozdag
		}}
	
	
		,
	journal={{European Journal of Pharmaceutics and Biopharmaceutics}}
		
			70
			
			,
	year={2008}
		
	

}

@incollection{b48,
	
	
		,
	title={{Development and evaluation of pH triggered in-situ ophthalmic gel formulation of ofloxacin}}
		,
	author={{
			PBPatel
		} and {
			DHShastri
		}}
		
	
	
		,
	journal={{American Journal of Pharmtech Research}}
		
			1
			
			,
	year={2011}
		
	

}

@incollection{b49,
	
	
		,
	title={{Effect of a single drop of latanoprost ophthalmic gel on intra ocular pressure in the treatment of glaucoma}}
		,
	author={{
			SVKulkarni
		} and {
			HNSandeep
		}}
		
	
	
		,
	journal={{International Journal of Pharmaceutical Sciences}}
		
			2
			
			,
	year={2010}
		
	

}

@incollection{b50,
	
	
		,
	title={{Nanoemulsion as a potential ophthalmic delivery system for dorzolamide hydrochloride}}
		,
	author={{
			OAHussein
		} and {
			HASalama
		}}
		
	
	
		,
	journal={{AAPS Pharmscitech}}
		
			10
			
			,
	year={2009}
		
	

}

@incollection{b51,
	
	
		,
	title={{Formulation and Invitro evaluation of cysteamine hydrochloride viscous solution for treatment of corneal cystinosis}}
		,
	author={{
			KoraygumuSibelbozdag
		}}
	
	
		,
	journal={{European Journal of Pharmaceutics and Biopharmaceutics}}
		
			70
			
			,
	year={2008}
		
	

}

@incollection{b52,
	
	
		,
	title={{Polyacrylic acid/ polyvinylpyrrolidone bipolymeric systems.i. Rheological and mucoadhesive properties of formulations potentially useful for the treatment of dry-eye-syndrome}}
		,
	author={{
			MatthiasOSigrid
		} and {
			K
		}}
		
	
	
		,
	journal={{European Journal of Pharmaceutics and Biopharmaceutics}}
		
			47
			
			,
	year={1999}
		
	

}

@incollection{b53,
	
	
		,
	title={{Cyclodextrin solubilization of carbonic anhydrase inhibitor drugs: formulation of dorzolamide eye drop microparticle suspension}}
		,
	author={{
			PJansook
		} and {
			EStefánsson
		}}
		
	
	
		,
	journal={{European Journal of Pharmaceutics and Biopharmaceutics}}
		
			76
			
			,
	year={2010}
		
	

}

@incollection{b54,
	
	
		,
	title={{Solubility enhancement of water insoluble drug for ophthalmic formulation}}
		,
	author={{
			SunishaKulkarni
		}}
	
	
		,
	journal={{Int. J. of Drug Delivery}}
		
			3
			
			,
	year={2011}
		
	

}

@incollection{b55,
	
	
		,
	title={{Ophthalmic drug delivery systems recent advances}}
		,
	author={{
			CLBourlais
		} and {
			LAcar
		}}
		
	
	
		,
	journal={{Progress In Retinal And Eye Research}}
		
			17
			
			,
	year={1998}
		
	

}

@incollection{b56,
	
	
		,
	title={{Topical semi-solid drug delivery: kinetics and tolerance of ophthalmic hydrogels}}
		,
	author={{
			MZignani
		} and {
			CTabatabay
		}}
		
	
	
		,
	journal={{Adv Drug Deliv Rev}}
		
			16
			
			,
	year={1995}
		
	

}

@incollection{b57,
	
	
		,
	title={{Selected polysaccharide at comparison for their mucoadhesiveness and effect on precorneal resident of different drugs in rabbit model}}
		,
	author={{
			GDColo
		} and {
			YZambito
		}}
		
	
	
		,
	journal={{Drug. Dev. and Ind. Pharmacy}}
		
			35
			
			,
	year={2009}
		
	

}

@incollection{b58,
	
	
		,
	title={{A novel poloxamers/ hyaluronic acid in situ forming hydrogel for drug delivery: rheological, mucoadhesive and in vitro release properties}}
		,
	author={{
			LMayol
		} and {
			FQuaglia
		}}
		
	
	
		,
	journal={{European Journal of Pharm and Biopharms}}
		
			70
			
			,
	year={2008}
		
	

}

@incollection{b59,
	
	
		,
	title={{Stimuli-sensitive hydrogels in controlled and sustained drug delivery}}
		,
	author={{
			RMasteikova
		} and {
			ZChalupova
		}}
		
	
	
		,
	journal={{Medicina}}
		
			39
			
			,
	year={2003}
		
	

}

@incollection{b60,
	
	
		,
	title={{A study on stability and in-vivo drug release of naphazoline and antazoline in situ gelling systems for ocular delivery}}
		,
	author={{
			GNShetty
		} and {
			RNCharyulu
		}}
		
	
	
		,
	journal={{Int J of Pharm Bio Sci}}
		
			4
			1
			
			,
	year={2013}
		
	

}

@incollection{b61,
	
	
		,
	title={{In-vivo evaluation of dexamethasone sodium phosphate nanoparticles for post cataract treatment}}
		,
	author={{
			VSankara
		}}
	
	
		,
	journal={{Pharmacologyonline}}
		
			8
			
			,
	year={2009}
		
	

}